Villers Canivet, France

Ronan Bureau

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Regional De Lutte Contre Le Cancer Francois Baclesse, Institut De Cancerologie De L'ouest Rene Gauducheau, Université De Caen Basse Normandie. Active years: 2019.


% Patents Active = 100.0


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ronan Bureau: Innovator in Cancer Treatment

Introduction

Ronan Bureau is a notable inventor based in Villers Canivet, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.

Latest Patents

Ronan Bureau holds a patent for "Mcl-1 modulating compounds for cancer treatment." This invention relates to compounds of formula (I) and their therapeutic use in the treatment of cancer. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Ronan has worked with esteemed institutions such as Université de Caen Basse Normandie and Institut de Cancérologie de l'Ouest René Gauducheau. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ronan has collaborated with talented individuals, including Grégory Burzicki and Jana Sopkova-de Oliveira Santos. These partnerships have enriched his research and expanded the impact of his work in cancer treatment.

Conclusion

Ronan Bureau's innovative contributions to cancer treatment through his patented compounds highlight his dedication to improving healthcare. His collaborations and career achievements reflect his significant role in advancing medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…